Evidence map›Paper›PMID 21498512›Full record

ArticleThe Journal of biological chemistry2011

Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1.

Casey Charvet, Wei-Li Liao, Gun-Young Heo, James Laird, Robert G Salomon, Illarion V Turko, Irina A Pikuleva

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Challenges and Opportunities in P450 Research on the Eye.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  3. Mass spectrometry-based retina proteomics.Mass spectrometry reviews · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Isolevuglandin adducts in disease.Antioxidants & redox signaling · 2015
    Review
  11. Article
  12. Review
  13. Cholesterol in the retina: the best is yet to come.Progress in retinal and eye research · 2014
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Casey CharvetDepartment of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland,Ohio 44106, USA .
Wei-Li Liao
Gun-Young Heo
James Laird
Robert G Salomon
Illarion V Turko
Irina A Pikuleva
Case Western Reserve University · USInstitute for Bioscience and Biotechnology Research

Funding

TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Paul S Park · 1997 to 2026
$17.7M
Significance of CYP46A1 and other P450s in retinal functionR01EY018383 · NEI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PIKULEVA, IRINA A · 2007 to 2024
$6.8M
VISUAL SCIENCES TRAINING PROGRAMT32EY007157 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Johannes Friedrich von Lintig · 2000 to 2026
$5.5M
Preprostaglandin Endoperoxides (supplement)R01GM021249 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI SALOMON, ROBERT GERD · 1985 to 2014
$5.2M
Cholesterol-metabolizing P450s and Alzheimer's diseaseK02AG024336 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI PIKULEVA, IRINA A · 2005 to 2009
$515k
NEI NIH HHS EY018383NEI NIH HHS P30 EY011373NEI NIH HHS P30 EY11373NEI NIH HHS R01 EY018383NEI NIH HHS T32 EY007157NIA NIH HHS AG024336NIA NIH HHS K02 AG024336NIGMS NIH HHS GM21249NIGMS NIH HHS R01 GM021249
6 · The paper itself

Abstract

We report the first peptide mapping and sequencing of an in vivo isolevuglandin-modified protein. Mitochondrial cytochrome P450 27A1 (CYP27A1) is a ubiquitous multifunctional sterol C27-hydroxylase that eliminates cholesterol and likely 7-ketocholesterol from the retina and many other tissues. We investigated the post-translational modification of this protein with isolevuglandins, arachidonate oxidation products. Treatment of purified recombinant CYP27A1 with authentic iso[4]levuglandin E(2) (iso[4]LGE(2)) in vitro diminished enzyme activity in a time- and phospholipid-dependent manner. A multiple reaction monitoring protocol was then developed to identify the sites and extent of iso[4]LGE(2) adduction. CYP27A1 exhibited only three Lys residues, Lys(134), Lys(358), and Lys(476), that readily interact with iso[4]LGE(2) in vitro. Such selective modification enabled the generation of an internal standard, (15)N-labeled CYP27A1 modified with iso[4]LGE(2), for the subsequent analysis of a human retinal sample. Two multiple reaction monitoring transitions arising from the peptide AVLK(358)(-C(20)H(26)O(3))ETLR in the retinal sample were observed that co-eluted with the corresponding two (15)N transitions from the supplemented standard. These data demonstrate that modified CYP27A1 is present in the retina. We suggest that such protein modification impairs sterol elimination and likely has other pathological sequelae. We also propose that the post-translational modifications identified in CYP27A1 exemplify a general mechanism whereby oxidative stress and inflammation deleteriously affect protein function, contributing, for example, to cholesterol-rich lesions associated with age-related macular degeneration and cardiovascular disease. The proteomic protocols developed in this study are generally applicable to characterization of lipid-derived oxidative protein modifications occurring in vivo, including proteins bound to membranes.

Indexed as

LipoylationProtein Processing, Post-TranslationalCardiovascular DiseasesCholestanetriol 26-MonooxygenaseEye ProteinsHumansMacular DegenerationMass SpectrometryMitochondrial ProteinsPeptide MappingRetinaCholestanetriol 26-MonooxygenaseCYP27A1 protein, humanEye ProteinsMitochondrial Proteins

Identifiers

PMID21498512
PMCPMC3121529
OpenAlexW2056476588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.